EUVIMEDEUVIMED entdecken
Crossref

Fibroblast growth factor 21 attenuates pulmonary ischemia/reperfusion injury via inhibiting endoplasmic reticulum stress-induced ferroptosis though FGFR1/PPARδ signaling pathway

Xinqiao Ye, Fang Pei, Wei Li, Jinping Xue, Xiuyun Huang, Jianming Huang, Liyan Zhang

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.113307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Xinqiao Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Ganzhou Hospital of Guangdong Provincial People's Hospital, Ganzhou Municipal Hospital, Ganzhou 341009, Jiangxi, Chin…. Hauptthemen laut MEDLINE: Endoplasmic Reticulum Stress, Ferroptosis, Fibroblast Growth Factors, PPAR delta. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Acute lung injury is a critical life-threatening complication of pulmonary and cardiac surgery with a high rate of morbidity and mortality. Fibroblast growth factor 21 (FGF21) has been reported to play an important role in protecting vital organs from damage. This study aims to investigate the potential protective role and mechanism of FGF21 in pulmonary ischemia/reperfusion (I/R)-induced acute lung injury. METHODS: A pulmonary epithelial cell line was treated with hypoxia/regeneration (H/R) in vitro and a mouse model of acute lung injury was induced with pulmonary I/R in vivo. Lung injury after pulmonary I/R was compared between FGF21-konckout (KO) mice and wild-type (WT) mice. Recombinant FGF21 was administrated in vivo and in vitro to determine its therapeutic effect. RESULTS: Circulating levels of FGF21 in mice with pulmonary I/R injury were significantly higher than in those without pulmonary I/R injury. Lung injury was aggravated in FGF21-KO mice compared with WT mice and the administration of FGF21 alleviated lung injury in mouse treated with I/R and pulmonary epithelial cell injury treated with H/R. FGF21 treatment decreased endoplasmic reticulum (ER) stress, Fe2+ and lipid reactive oxygen species (ROS) contents and GPX4 expression and increased PTGS2 levels. Mechanistically, FGF21 upregulated the expression of FGFR1 and PPARδ, ameliorated ER stress and ER stress induced-ferroptosis. Furthermore, FGF21 increased the expression level of PPARδ in pulmonary epithelial cell exposed to H/R, which was inhibited by FGFR1 inhibitor (PD173074). The protective effects of FGF21 were abolished by co-treatment with PPARδ inhibitor (GSK0660), indicating FGF21 attenuated ER stress-induced ferroptosis by dependent on FGFR1/PPARδ signaling pathway. CONCLUSION: Our study reveals that FGF21 protects against pulmonary I/R injury via inhibiting ER stress-induced ferroptosis though FGFR1/PPARδ signaling pathway. Boosting endogenous FGF21 or the administration of recombinant FGF21 could be promising therapeutic strategies for pulmonary IRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoplasmic Reticulum StressFerroptosisFibroblast Growth FactorsPPAR deltaReceptor, Fibroblast Growth Factor, Type 1Reperfusion InjurySignal TransductionAnimalsHumansMaleMiceAcute Lung InjuryCell LineDisease Models, AnimalLungMice, Inbred C57BLMice, KnockoutReactive Oxygen Species

Stichwörter der Autor:innen

Endoplasmic reticulum stressFerroptosisFibroblast growth factor 21Peroxisome proliferator-activated receptor δPulmonary ischemia reperfusion injury

Substanzen

Fgfr1 protein, mousefibroblast growth factor 21Fibroblast Growth FactorsPPAR deltaReactive Oxygen SpeciesReceptor, Fibroblast Growth Factor, Type 1

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Ganzhou Hospital of Guangdong Provincial People's Hospital, Ganzhou Municipal Hospital, Ganzhou 341009, Jiangxi, China.
  • Department of Cardiology, Ganzhou Hospital of Guangdong Provincial People's Hospital, Ganzhou Municipal Hospital, Ganzhou 341009, Jiangxi, China. Electronic address: gypeifang@163.com.
  • People's Hospital of Ningdu County, Ganzhou 342899, Jiangxi, China.
  • Xinfeng Hospital of Traditional Chinese Midicine, Ganzhou 341699, Jiangxi, China.
  • Dingnan Second Hospital, Ganzhou 341999, Jiangxi, China.
  • Department of Clinical Laboratory, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 519041, Guangdong, China.

Zitieren

APA

Ye, X., Pei, F., Li, W., Xue, J., Huang, X., Huang, J., & Zhang, L. (2024). Fibroblast growth factor 21 attenuates pulmonary ischemia/reperfusion injury via inhibiting endoplasmic reticulum stress-induced ferroptosis though FGFR1/PPARδ signaling pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113307

Vancouver

Ye X, Pei F, Li W, Xue J, Huang X, Huang J, et al. Fibroblast growth factor 21 attenuates pulmonary ischemia/reperfusion injury via inhibiting endoplasmic reticulum stress-induced ferroptosis though FGFR1/PPARδ signaling pathway. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113307

BibTeX
@article{Ye2024,
  author = {Ye, Xinqiao and Pei, Fang and Li, Wei and Xue, Jinping and Huang, Xiuyun and Huang, Jianming and Zhang, Liyan},
  title = {Fibroblast growth factor 21 attenuates pulmonary ischemia/reperfusion injury via inhibiting endoplasmic reticulum stress-induced ferroptosis though FGFR1/PPARδ signaling pathway},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.113307}
}
Kostenlos starten →